Adhera Therapeutics (ATRX) Financial Statements

Adhera Therapeutics's market cap is currently $722.00. The company's EPS TTM is $-1.249; its P/E ratio is ―; Adhera Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.